SR141716

SR141716, also known as Rimonabant, is a drug that was developed to help with weight loss and smoking cessation by blocking the CB1 cannabinoid receptor in the brain. This receptor is involved in regulating appetite, mood, and reward. By inhibiting it, SR141716 reduces hunger and cravings. However, due to concerns about mental health side effects, such as depression and anxiety, the drug was withdrawn from the market in many countries. It is a research compound used to study the endocannabinoid system's role in various physiological processes.